Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: lucky,mydog, techmover, bz777, gentle09, HighYieldStocks, Mykkus
Search This Board: 
Last Post: 1/18/2018 10:16:04 PM - Followers: 439 - Board type: Free - Posts Today: 48



ARYC is a Silicon Valley company that is currently trading under a penny per share but not for much longer. Sales of its microarray products are in excess of $30,000 to $40,000 per day!! Please research this Silicon Valley company. This company has potential of trading in excess of $5 per share:


Follow  @Arrayit and $ARYC on Twitter


Arrayit Corporation on Facebook 


No share increase per CEO.....!!!!!..  AND......Trading at .6x earnings....... Yes, point 6 times!

Estimated earnings of $8 million last year and it is also located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry. 


Trading at an incredibly low share price under a penny.


2 contracts signed last year for a total of approximately $51 million over the next 3 years ......


No other sub penny company has the potential of ARYC  


Please check out their tweets @Arrayit or go to their Facebook page: Arrayit Corporation 




Please check their products that are selling in the tens of thousands of dollars daily. 


Link to their products:


Arrayit's new corporate headquarters, located at 927 Thompson Place, Sunnyvale, California, 94085, feature 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities.


ARYC is continuing  a strong and steady move up on steady  volume.  Please take some time to review the ARYC board with due diligence done by investors.



Arrayit reports $46,000 microarray services sale to a leading proteomics research company located in the central USA 

(link: ;… 


Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.


ARYC: Arrayit Corporation 


@Arrayit on Twitter 


Link to their products:


ARYC also owns 40 million shares of AVDX. A value of $12 million +


Arrayit wins technical specification bid on $110,000 microarray instrument government tender with top life sciences distributor in India.


$ARYC.....Arrayit on-line company Store sales exceed $54.5 million all-time on 226,285 microarray products and services sold



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the
Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection



About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#64203  Sticky Note ARYC GUIDE FOR ALL WHO ARE NEW - bz777 01/11/18 10:09:34 PM
#64201  Sticky Note Sub .01 Silicon Valley Biotech techmover 01/11/18 05:34:23 PM
#64198  Sticky Note To all who are new to the ARYC UndervaluedStocks 01/11/18 05:25:58 PM
#64194  Sticky Note TO REPORT ARYC TO THE SEC..... lucky,mydog 01/11/18 04:53:39 PM
#61908  Sticky Note For new investors: Please DD Silicon Valley biotech, gentle09 12/05/17 06:21:44 PM
#59181  Sticky Note For those who are new to Arrayit Corporation, HighYieldStocks 10/26/17 12:28:09 PM
#64488   Financials out yet? Sorry wrong board! Lol Liuhisn 01/18/18 10:16:04 PM
#64487   What does this have to do with ARYC? jhols001 01/18/18 09:57:28 PM
#64486   It’s just a matter of time and everyone Penny Traders Club 01/18/18 09:12:26 PM
#64485   Great article thanks for sharing. Penny Traders Club 01/18/18 09:11:32 PM
#64484   From the BBC. Cancer blood test ‘enormously exciting’ - yorky 01/18/18 08:35:38 PM
#64479   It's tough to make up that many tweets...tougher Full Contact Yoga 01/18/18 04:30:44 PM
#64478   No sad,it is a reason celebrate for this company. Hugie 01/18/18 02:06:55 PM
#64477   You can all look forward for next round Hugie 01/18/18 01:42:25 PM
#64476   Looking forward to your next sales spread sheet. rh22 01/18/18 01:36:00 PM
#64475   NEW tweet...Arrayit science team reports technical inquiry from HighYieldStocks 01/18/18 01:17:24 PM
#64474   NEW tweet...Arrayit sales and marketing team quotes $11,300 HighYieldStocks 01/18/18 01:17:15 PM
#64473   NEW tweet...Arrayit sales and marketing team reports patented HighYieldStocks 01/18/18 01:17:07 PM
#64471   Same as last year! jrsh 01/18/18 12:47:11 PM
#64470   I know they have non disclosure agreements in place UndervaluedStocks 01/18/18 12:45:15 PM
#64469   Nothing official,sorry this is no DD.. Hugie 01/18/18 12:45:05 PM
#64468   You know that if they do not give jrsh 01/18/18 12:44:29 PM
#64467   ARYC Potential revenue streams partial list: bz777 01/18/18 12:40:14 PM
#64466   Their products are also sold by secondary lab UndervaluedStocks 01/18/18 12:38:43 PM
#64465 UndervaluedStocks 01/18/18 12:37:54 PM
#64464   Youtube video link: UndervaluedStocks 01/18/18 12:37:11 PM
#64463   ARYC on Facebook UndervaluedStocks 01/18/18 12:36:43 PM
#64462   Arrayit Corporation patents: UndervaluedStocks 01/18/18 12:36:14 PM
#64461   ARYC charts: UndervaluedStocks 01/18/18 12:35:42 PM
#64460   Any audit do not take over a year,just Hugie 01/18/18 12:35:39 PM
#64459 UndervaluedStocks 01/18/18 12:35:18 PM
#64458 UndervaluedStocks 01/18/18 12:34:44 PM
#64457   What a lot of people seem not to rh22 01/18/18 12:32:09 PM
#64456   This is what passes for DD on ARC. rh22 01/18/18 12:27:38 PM
#64455   ARYC is not a 'silicon valley biotech". rh22 01/18/18 12:20:07 PM
#64454   How outrageous. rh22 01/18/18 12:18:21 PM
#64453   Arrayit can not be a good company when Hugie 01/18/18 12:17:09 PM
#64452   NEW tweet...Arrayit shipping department ships microarray reagents sale HighYieldStocks 01/18/18 11:45:55 AM
#64451   when they tweeted last March about the 3 jrsh 01/18/18 11:41:54 AM
#64450   NEW tweet...Arrayit technical support team reports tech support HighYieldStocks 01/18/18 11:25:04 AM
#64449   NEW tweet...Arrayit sales and marketing team reports $8,800 HighYieldStocks 01/18/18 11:24:56 AM
#64448   Hold long and strong you won’t regret it! Penny Traders Club 01/18/18 09:53:11 AM
#64447   Really! Penny Traders Club 01/18/18 09:52:33 AM
#64446   Too bad isn't it that this will never techmover 01/18/18 09:51:28 AM
#64445   There is 1 million on the bid at jrsh 01/18/18 09:39:51 AM
#64444   Looking forward to great things here! Play4keeps2 01/18/18 06:20:35 AM
#64443   an extract from Supreme Leadership jrsh 01/18/18 06:19:55 AM
#64442   People are just impatient. Patience pays off if TravO 01/18/18 12:45:57 AM
#64441   For those that are holding, strong and long Jeffpacman 01/18/18 12:19:01 AM
#64439   Silicon Valley biotech ARYC @Arrayit Arrayit Corporation on FB Trading UndervaluedStocks 01/17/18 09:09:58 PM
#64438   All these statements may be somewhat accurate, but r2g2 01/17/18 07:31:53 PM
#64436  Restored Arrayit senior management featured in top business management jrsh 01/17/18 04:37:00 PM
#64435   Really? OK - that's your prerogative Delsurfer 01/17/18 04:20:31 PM
#64434   NEW tweet...Arrayit surface chemistry is used in futuristic HighYieldStocks 01/17/18 04:10:12 PM
#64433   No, it's $3.75 per share and a competitor Alyssa 01/17/18 03:39:01 PM
#64432   maybe 3.75 for the company but even that lucky,mydog 01/17/18 03:36:44 PM